Telix Pharmaceuticals Ltd.
ISIN AU000000TLX2
|WKN A2H7JK
Overview
Description
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.
Healthcare Healthcare Equipment Other Medical Devices Australia
Financials
Key metrics
| Market capitalisation, EUR | 5,177.03 m |
| EPS, EUR | - |
| P/B ratio | 21.24 |
| P/E ratio | 170.23 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 308.86 m |
| Net income, EUR | 3.20 m |
| Profit margin | 1.04% |
What ETF is Telix Pharmaceuticals Ltd. in?
There are 14 ETFs which contain Telix Pharmaceuticals Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Telix Pharmaceuticals Ltd. is the Fidelity Sustainable Research Enhanced Pacific ex-Japan Equity UCITS ETF Acc.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| WisdomTree Megatrends UCITS ETF USD | 0.03% | Equity World Social/Environmental Innovation | 650 | 0.50% | 15 | +16.21% | A3EYCN | IE0000902GT6 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Acc) | 0.01% | Equity World | 3,576 | 0.17% | 2,175 | +25.00% | A1JJTD | IE00B3YLTY66 |
| Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing | 0.06% | Equity Asia Pacific Social/Environmental | 2,058 | 0.17% | 12 | +8.88% | A3DJRB | IE0008T6IUX0 |
| SPDR MSCI World Small Cap UCITS ETF | 0.04% | Equity World Small Cap | 3,545 | 0.45% | 890 | +16.42% | A1W56P | IE00BCBJG560 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.00% | Equity World Social/Environmental | 5,774 | 0.24% | 407 | +26.93% | A2QL8V | IE00BNG8L385 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Dist) | 0.01% | Equity World | 3,576 | 0.17% | 14 | - | A40F93 | IE000DD75KQ5 |
| Fidelity Sustainable Research Enhanced Pacific ex-Japan Equity UCITS ETF Acc | 0.38% | Equity Asia Pacific Social/Environmental | 109 | 0.20% | 460 | +11.59% | A2QD42 | IE00BNGFMY78 |
| iShares MSCI World Small Cap UCITS ETF | 0.05% | Equity World Small Cap | 3,321 | 0.35% | 4,796 | +16.96% | A2DWBY | IE00BF4RFH31 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.01% | Equity World Small Cap | 2,278 | 0.35% | 59 | +16.12% | A3C14G | IE000T9EOCL3 |
| Invesco Dow Jones Islamic Global Developed Markets UCITS ETF Acc | 0.01% | Equity World Islamic Investing | 1,592 | 0.40% | 836 | +28.59% | A3C6Z0 | IE000UOXRAM8 |
| HSBC MSCI World Small Cap ESG UCITS ETF USD (Acc) | 0.10% | Equity World Small Cap | 1,144 | 0.25% | 59 | +14.91% | A3DUNV | IE000C692SN6 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.00% | Equity World Social/Environmental | 5,774 | 0.24% | 450 | +26.57% | A2QL8U | IE00BNG8L278 |
| Xtrackers S&P/ASX 200 UCITS ETF 1D | 0.25% | Equity Australia | 200 | 0.50% | 58 | +7.71% | DBX1A2 | LU0328474803 |
| Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Accumulating | 0.06% | Equity Asia Pacific Social/Environmental | 2,058 | 0.17% | 31 | +8.67% | A3DJRA | IE000GOJO2A3 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.